Athira Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athira Pharma and other ETFs, options, and stocks.About ATHA
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018.
CEOMark J. Litton
CEOMark J. Litton
Employees26
Employees26
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded2011
Founded2011
Employees26
Employees26
ATHA Key Statistics
Market cap15.24M
Market cap15.24M
Price-Earnings ratio-0.40
Price-Earnings ratio-0.40
Dividend yield—
Dividend yield—
Average volume20.54K
Average volume20.54K
High today$3.97
High today$3.97
Low today$3.83
Low today$3.83
Open price$3.87
Open price$3.87
Volume8.37K
Volume8.37K
52 Week high$6.68
52 Week high$6.68
52 Week low$2.20
52 Week low$2.20
Stock Snapshot
The current Athira Pharma(ATHA) stock price is $3.91, with a market capitalization of 15.24M. The stock trades at a price-to-earnings (P/E) ratio of -0.40.
On 2025-12-04, Athira Pharma(ATHA) stock moved within a range of $3.83 to $3.97. With shares now at $3.91, the stock is trading +2.1% above its intraday low and -1.5% below the session's peak.
Trading activity shows a volume of 8.37K, compared to an average daily volume of 20.54K.
The stock's 52-week range extends from a low of $2.20 to a high of $6.68.
The stock's 52-week range extends from a low of $2.20 to a high of $6.68.
People also own
Based on the portfolios of people who own ATHA. This list is generated using Robinhood data, and it’s not a recommendation.